CSI Market
Sign In | Register

Adaptive Biotechnologies (ADPT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ADPT Annual Balance Sheets →
Balance sheet data covering Adaptive Biotechnologies–Sep 30 2025 offers a view into how Sep 30 2026's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ADPT/balance-sheets
https://api.csimarket.com/api/v1/companies/ADPT/fundamentals
https://api.csimarket.com/api/v1/companies/ADPT/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent75.62
Available-for-sale Securities, Debt Securities, Current MA223.34
Cash & Short-term Investments298.00
Accounts receivable66.67
Inventories10.06
Prepaid Expense And Other Assets Current17.01
Total Current Assets392.69
Equipment/Property/Plant Net27.97
Goodwill net118.97
Intangible Assets0.46
Long-term investments101.23
Other Assets, Noncurrent41.81
Restricted Cash Noncurrent2.71
Total Assets683.12
Liabilities
Accounts Payable, Current AC6.53
Accrued Liabilities, Current15.11
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current77.33
Total Current Liabilities98.97
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent400.26
Contract With Customer Liability Current49.40
Contract With Customer Liability Noncurrent0.81
Total Liabilities499.23
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock1,597.75
Retained Earnings / Accumulated Deficit-1,420.27
Accumulated Other Comprehensive Income-1.29
Other Equity-1.29
Common Stockholder's Equity176.21
Non-controlling interests & other7.68
Total Stockholder's Equity183.89
Liabilities & Stockholder's Equity683.12
4 historic quarters locked

Sign in to unlock the full Adaptive Biotechnologies balance sheet history.

Sign In Create Free Account

About Adaptive Biotechnologies Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-447411

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI